According to the previous literatures, Myd88 was documented as a tumor promoter in various cancers, especially in HCC, it was shown to promote tumor cell proliferation, invasion, metastasis through activation of NF-κB and PI3K/AKT signal pathways. Here, AKT1 is linked to hepatocellular carcinoma.